title: A case of Trousseau syndrome associated with a mucosa-associated lymphoid tissue lymphoma disseminated to the mesenteric adipose tissue.
abstract: A 66-year-old man with recurrent stroke within a short period of time was referred to our department from the neurology department to rule out any malignancy. An endoscopic examination revealed a white depressed lesion in the body of the stomach, and computed tomography revealed a high-density area in the mesentery around the stomach. A mucosa-associated lymphoid tissue (MALT) lymphoma was detected from both the stomach biopsy and resected mesenteric specimen. Systemic chemotherapy was administered for the MALT lymphoma (Lugano classification stage IV). Cerebral infarction did not occur after the treatment. We concluded that Trousseau syndrome associated with the MALT lymphoma disseminated to the mesenteric adipose tissue. A MALT lymphoma has a small probability of occurring in Trousseau syndrome.
authors.affiliation: Department of Gastroenterology, Fukui Prefectural Hospital.
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Yasuharu
authors.initials: Y
authors.lastname: Kaizaki
authors.forename: Manami
authors.initials: M
authors.lastname: Utsunomiya
authors.forename: Atsushi
authors.initials: A
authors.lastname: Aritsuka
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Naito
authors.forename: Haruo
authors.initials: H
authors.lastname: Fujinaga
authors.forename: Kenkei
authors.initials: K
authors.lastname: Hasatani
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Aoyagi
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Ibe
authors.forename: Tamon
authors.initials: T
authors.lastname: Miyanaga
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008643:Mesentery / Q000000981:diagnostic imaging; D009361:Neoplasm Invasiveness; D018205:Neoplasms, Adipose Tissue / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D000069283:Rituximab / Q000008:administration & dosage; D020521:Stroke / Q000209:etiology*; D013577:Syndrome; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone